How a DuPont Carve-Out Made a Comeback
Updated Nov. 3, 2017 12:39 p.m. ET 
 
 It was supposed to be the worst spinoff in the history of spins. When DuPont Co. cleaved off its performance chemicals business as Chemours Co. in June 2015, doubts ran high about the company’s future.
Activist investor Nelson Peltz, whose Trian Fund Management received Chemours shares as a DuPont shareholder, sold off the stake within six months. A year after its launch, famed short-seller Andrew Left announced he was betting against the stock with a report titled “Chemours is a bankruptcy waiting to happen.”
...
